Treatment of depression in children and adolescents

Pediatric Annals

Volumn 40, Issue 11, 2011, Pages 548-555

  Bujoreanu, Simona ^a   Benhayon, David ^b   Szigethy, Eva ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; LITHIUM; MIRTAZAPINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOPIRAMATE; TRAZODONE; VALPROATE SEMISODIUM; VENLAFAXINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY DISORDER; ARTICLE; CHILD PSYCHIATRY; COGNITIVE THERAPY; COMORBIDITY; COMPETITIVE INHIBITION; DAILY LIFE ACTIVITY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; EMOTIONALITY; ENERGY; ENVIRONMENTAL FACTOR; EVIDENCE BASED PRACTICE; FAMILY HISTORY; FOLLOW UP; HUMAN; MAJOR DEPRESSION; MENTAL INSTABILITY; OUTPATIENT CARE; PATIENT MONITORING; PROBLEM SOLVING; PSYCHOEDUCATION; PSYCHOSOCIAL WITHDRAWAL; PSYCHOTHERAPY; RISK FACTOR; SOCIAL STATUS; TREATMENT RESPONSE; ADOLESCENT; CHILD; MULTIMODALITY CANCER THERAPY; REVIEW;

ADOLESCENT; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHILD; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSION; HUMANS; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 84855373765     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20111007-05     Document Type: Article

References (33)

1. Lewinsohn PM, Rohde P, Seeley JR, Klein DN, Gotlib IH. Natural course of adolescent major depressive disorder in a community sample: predictors of recurrence in young adults. Am J Psychiatry. 2000;157(10):1584-1591.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington: American Psychiatric Association; 2000.
3. Birmaher B, Brent D; AACAP Work Group on Quality Issues, Bernet W, Bukstein O, Walter H, et al. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 2007;46(11):1503-1526.
4. Lenze SN, Pautsch J, Luby J. Parent-child interaction therapy emotion development: a novel treatment for depression in preschool children. Depress Anxiety. 2011;28(2):153-159.
5. Pediatr Ann. 2011;40(10).
6. Merikangas KR, He JP, Burstein M, et al. Service utilization for lifetime mental disorders in U.S. adolescents: results of the National Comorbidity Survey-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2011;50(1):32-45.
7. Shaw RJ, Spratt EG, Bernard RS, DeMaso DR. Somatoform disorders. In: Shaw RJ, DeMaso DR, eds. Textbook of Pediatric Psychosomatic Medicine. Arlington, VA US: American Psychiatric Publishing, Inc.; 2010:121-139.
8. Chambless DL, Sanderson WC., Shoham V, et al. An update on empirically validated therapies. Clin Psychol. 1996;49:5-18.
9. David-Ferdon C, Kaslow, NJ. Evidence- Based Psychosocial Treatments for Child and Adolescent Depression. J Clin Child Adolesc Psychol. 2008;37(1):62-104.
10. Mufson L. Interpersonal psychotherapy for depressed adolescents (IPT-A): Extending the reach from academic to community settings. Child and Adolescent Mental Health. 2010;15(2):66-72.
11. Weisz JR, Southam-Gerow MA, Gordis EB, Connor-Smith JK, Chu BC, Langer DA, McLeod BD, Jensen-Doss A, Updegraff A, Weiss B Cognitive-behavioral therapy versus usual clinical care for youth depression: an initial test of transportability to community clinics and clinicians. J Consult Clin Psychol. 2009;77(3):383-396.
12. March JS, Vitiello B. Clinical messages from the Treatment for Adolescents With Depression Study (TADS). Am J Psychiatry. 2009;166(10):1118-1123.
13. McLeod BD. Relation of the alliance with outcomes in youth psychotherapy: a meta-analysis. Clin Psychol Rev. 2011;31(4):603-616.
14. Dulcan MK. Dulcan's Textbook of Child and Adolescent Psychiatry. American Psychiatric Publishing, Inc. Arlington, VA. 2010.
15. Campo JV, Perel J, Lucas A, et al. Citalopram treatment of pediatric recurrent abdominal pain and comorbid internalizing disorders: an exploratory study. J Am Acad Child Adolesc Psychiatry. 2004;43(10):1234-1242.
16. Emslie GJ, Rush AJ, Weinberg WA, et al. A double-blind, randomized, placebo-controlled trial of fl uoxetine in children and adolescents with depression. Arch Gen Psychiatry. 1997;54(11):1031-1037.
17. Emslie GJ, Mayes T, Porta G, et al. Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes. Am J Psychiatry. 2010;167(7):782-791.
18. Emslie GJ, Findling RL, Yeung PP, Kunz NR, Li Y. Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials. J Am Acad Child Adolesc Psychiatry. 2007;46(4):479-488.
19. Daviss WB, Perel JM, Brent DA, et al. Acute antidepressant response and plasma levels of bupropion and metabolites in a pediatricaged sample: an exploratory study. Ther Drug Monit. 2006;28(2):190-198.
20. Delgado SV, Saldaña SN, Barzman DH, Coffey B. Response to duloxetine in a depressed, treatment- resistant adolescent female. J Child Adolesc Psychopharmacol. 2007;17(6):889-894.
21. Hazell P, O'Connell D, Heathcote D, Henry D. Tricyclic drugs for depression in children and adolescents. Cochrane Database Syst Rev. 2002(2): CD002317.
22. March J, Silva S, Curry J, et al. The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up. Am J Psychiatry. 2009;166(10):1141-1149.
23. Reinecke MA, Curry JF, March JS. Findings from the Treatment for Adolescents with Depression Study (TADS): what have we learned? What do we need to know? J Clin Child Adolesc Psychol. 2009;38(6):761-767.
24. Melvin GA, Tonge BJ, King NJ, Heyne D, Gordon MS, Klimkeit E. A comparison of cognitivebehavioral therapy, sertraline, and their combination for adolescent depression. J Am Acad Child Adolesc Psychiatry. 2006;45(10):1151-1161.
25. Rushton JL, Clark SJ, Freed GL. Primary care role in the management of childhood depression: a comparison of pediatricians and family physicians. Pediatrics. 2000;105(4 Pt 2):957-962.
26. Stein RE, Zitner LE, Jensen PS. Interventions for adolescent depression in primary care. Pediatrics. 2006;118(2):669-682.
27. Asarnow JR, Jaycox LH, Duan N, et al. Effectiveness of a quality improvement intervention for adolescent depression in primary care clinics: a randomized controlled trial. JAMA. 2005;293(3):311-319.
28. US Food and Drug Administration. "Black Box" Warning for Antidepressants. 2004. Available at: www.fda.gov/Safety/Med- Watch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm155488.htm. Accessed Sept. 30, 2011.
29. Dudley M, Goldney R, Hadzi-Pavlovic D. Are adolescents dying by suicide taking SSRI antidepressants? A review of observational studies. Australas Psychiatry. 2010;18(3):242-245.
30. Substance Abuse and Mental Health Services Administration. National Registry of Evidence- Based Programs and Practices. 2011. Available at www.nrepp.samhsa.gov. Accessed Sept. 30, 2011.
31. Gillham JE, Hamilton J, Freres DR, Patton K, Gallop R. Preventing depression among early adolescents in the primary care setting: a randomized controlled study of the Penn Resiliency Program. J Abnorm Child Psychol. 2006;34(2):203-219.
32. Garber J, Clarke GN, Weersing VR, et al. Prevention of depression in at-risk adolescents: a randomized controlled trial. JAMA. 2009;301(21):2215-2224.
33. Szigethy E, Kenney E, Carpenter J, Hardy DM, Fairclough D, Bousvaros A, Keljo D, Weisz J, Beardslee WR, Noll R, De-Maso DR. Cognitive-behavioral therapy for adolescents with inflammatory bowel disease and subsyndromal depression. J Am Acad Child Adolesc Psychiatry. 2007;46(10):1290-1298.